everal recent clinical studies have reported negative clinical outcomes in certain groups of patients receiving transfusion of red blood cells (RBCs) for anemia (1) (2) (3) (4) (5) . For example, in critically ill pediatric or adult patients with anemia, mortality, and major morbidity in those randomly assigned to a liberal RBC transfusion strategy were not superior to those transfused according to a conservative strategy (1, 2). Although the uncertainty surrounding optimal transfusion thresholds and storage times continues and has appropriately given rise to new clinical trials examining outcomes as a function of RBC storage duration, a basic and translational re-examination of the "storage lesions" in the RBC is also needed. Functionally relevant biochemical and morphologic changes during RBC storage have been recognized for decades. Recently, the recognition that RBCs participate directly and actively, rather than only passively, in the regulation of blood flow and thus O 2 delivery has informed this re-examination. For example, we and others reported that early after collection, the ability of RBCs to relax blood vessels in hypoxia is significantly reduced as are the S-nitrosothiol mediators of this RBC-dependent vasodilator activity (6, 7).
S
everal recent clinical studies have reported negative clinical outcomes in certain groups of patients receiving transfusion of red blood cells (RBCs) for anemia (1) (2) (3) (4) (5) . For example, in critically ill pediatric or adult patients with anemia, mortality, and major morbidity in those randomly assigned to a liberal RBC transfusion strategy were not superior to those transfused according to a conservative strategy (1, 2) . Although the uncertainty surrounding optimal transfusion thresholds and storage times continues and has appropriately given rise to new clinical trials examining outcomes as a function of RBC storage duration, a basic and translational re-examination of the "storage lesions" in the RBC is also needed. Functionally relevant biochemical and morphologic changes during RBC storage have been recognized for decades. Recently, the recognition that RBCs participate directly and actively, rather than only passively, in the regulation of blood flow and thus O 2 delivery has informed this re-examination. For example, we and others reported that early after collection, the ability of RBCs to relax blood vessels in hypoxia is significantly reduced as are the S-nitrosothiol mediators of this RBC-dependent vasodilator activity (6, 7) .
Vasodilation can also be mediated by adenosine-5Ј-triphosphate (ATP), and more generally signaling by exported ATP has been demonstrated in a variety of cell types, including the RBC (8, 9) . The conduit for ATP release from the RBC appears to be the pannexin 1 hemichannel (10) . The efflux of ATP from RBCs can be inhibited by pannexin-1 inhibitors or by the cystic fibrosis transmembrane conductance regulator inhibitor glibenclamide (GLIB, which also blocks ATP-sensitive potassium [K ϩ ATP ] channels) (8, 10 -13) . In RBCs stored in additive solutions used currently, ATP levels are well maintained, falling only approximately 40% by the 42-day expiration (14) . However, little is known regarding the influence of storage on ATP export from RBCs or of the resulting functional changes, if any.
We tested the hypotheses that: 1) the ability of RBCs to release ATP declines during storage; and 2) the consequent impairment in RBC-ATP release promotes endothelial adhesion of RBCs. We also studied the ATP-sensitive sequelae of RBC transfusion in the lung, which is the first organ to encounter transfused RBCs and is frequently adversely impacted according to clinical studies of outcomes after RBC transfusion (1) (2) (3) . Collectively, our new findings point to a critical role for ATP exported from the normal RBC in preventing endothelial injury.
MATERIALS AND METHODS

Materials and Mice.
Reagents were purchased from Sigma (St Louis, MO) except where otherwise noted. Experiments involving mice were approved by the Duke Institutional Animal Care and Use Committee, and the collection and use of human blood was approved by the Duke Institutional Review Board. Nude mice (9 -15 wks) purchased from a Duke core facility were housed under specific pathogenfree conditions until the day of an experiment. C57BL6 mice were purchased from Jackson Labs and/or bred at Duke.
Collection and Preparation of RBCs. After written informed consent and under an institutional review board-approved protocol, venous blood was drawn through an antecubital vein of healthy volunteers into either Vacutainer tubes or syringes containing either EDTA or sodium heparin (50 U/mL) and kept on ice. Fresh RBCs were separated centrifugally, not leukoreduced except where specifically noted, and washed twice using excess phosphate-buffered saline (PBS) containing 0.1 mM diethylaminetetrapentaacetic acid. Stored, leukoreduced RBCs were obtained either from segments of banked RBC units stored by Duke Medical Center Transfusion Services or commercially (Interstate Blood Bank, Memphis, TN). The additive solutions used for stored, leukoreduced RBCs were: AS-1 (40% of unit sources), AS-3 (56%), or CPDA (4%). Aliquots were removed aseptically, washed twice with excess PBS (with 0.1 mM diethylaminetetrapentaacetic acid), and resuspended at a hematocrit of 35% before use.
In vitro ATP release from RBCs was assayed in Krebs buffer, pH 7.40, and bubbled with 21% O 2 /5% CO 2 /balance N 2 ("normoxia") or 0% O 2 /5% CO 2 /balance N 2 ("hypoxia") at 37°C. RBC final concentration was 0.4% hematocrit (i.e., 0.4% vol/vol). Assays were conducted on the postcentrifugation supernatant using a standard luciferase assay. PO 2 was measured using a portable O 2 electrode calibrated daily (Mettler; Thermo, Pittsburgh, PA) was 5-10 mm Hg (approximately 1% O 2 ) under "hypoxic" conditions. The gas flow through the buffer was kept equal under the two conditions. Preliminary experiments indicated that on exposure to hypoxia, ATP release from RBCs reached a plateau 2 mins later, and levels at 10 mins were similar (not shown). We therefore used a 5-min time point in subsequent in vitro studies of the determinants and consequences of RBC ATP release.
RBC Exposure to GLIB or Carbenoxolone. GLIB (10 mM stock solution prepared daily) was dissolved in 25 M NaOH supplemented with 50 mg/mL dextrose as previously described (12) , and a final concentration of 10 M was used. Carbenoxolone (CBX) was dissolved in PBS; final concentration was 100 M in RBC exposures. After exposure (30 mins, 25°C) to GLIB, CBX, or vehicle, RBCs were washed twice with excess PBS. Preliminary data using the ectonucleotidase (ATPase) inhibitor ARL67156 indicated that extracellular ATPase(s) had little effect on the accumulation of released or added ATP (data not shown) under these conditions and therefore ATPase inhibitors were not used thereafter.
RBC Adhesion Assays. Graduated-height flow chambers were used to quantify adhesion of RBCs to human umbilical vein endothelial cells (HUVECs) grown to confluence on glass slides precoated with 2% gelatin as described (15) . Temperature was maintained at 37°C, and adhesion was quantified by counting the number of adherent cells before and 5 mins after fluidic flow began. Percent adherence was calculated as 100 ϫ the number of cells adhering after flow begins divided by the number of cells adhering before flow began. HUVECs washed with PBS containing Ca 2ϩ and Mg 2ϩ were exposed in room air to either fresh or stored packed RBCs at 0.2% hematocrit (i.e., 0.2% vol/vol in PBS with Ca 2ϩ and Mg 2ϩ ) after RBC washing in PBS with Ca 2ϩ and Mg 2ϩ . We did not detect any hemolysis in the effluent from flow chambers in adhesion experiments. In some experiments, RBCs were pretreated with GLIB (final concentration, 10 M) or preincubated with anti-RBC adhesion receptor antibodies before adhesion assays. In other experiments, HUVECs were exposed to RBCs in the presence of apyrase (5 U/mL in PBS with Ca 2ϩ and Mg 2ϩ ). In some experiments, HUVECs were preincubated with extracellular ATP or mAbs as indicated. See also Supplemental Digital Content 1 (http://links.lww.com/CCM/A270).
Adhesion receptor antibodies were obtained from the following sources: anti-LandsteinerWiener (LW) Ab (mouse polyclonal antihuman, B01P) from Abnova (Taipei, Taiwan), anti-CD44 (mouse monoclonal antihuman, MS-668-PABX) from Thermo Scientific (Fremont, CA), anti-CD47 (mouse monoclonal antihuman, sc-12730) from Santa Cruz Biotechnology (Santa Cruz, CA), and anti-␣v␤ 3 integrin (mouse monoclonal antihuman, LM609) from Millipore (Temecula, CA). RBCs or HUVECs were incubated with saturating Ab concentrations (25 or 20 g/mL, respectively) for 45 mins at 25°C or 37°C, respectively. Murine myeloma protein P3x63/Ag8 (P3 ascitic fluid, 1:500 dilution) was grown in the Telen lab and used as a nonreactive control immunoglobulin in specified mAb studies.
RBC deformability was measured in washed RBCs suspended in polyvinylpyrrolidone using an ektacytometer (laser-assisted optical rotational cell analyzer; Mechatronics, Zwaag, The Netherlands) as previously described (7) .
RBC Transfusion Model in Nude Mice. Nude mice 9 -15 wks of age were anesthetized with sodium pentobarbital, cannulated with a tracheostomy, and positioned on a warming platform. A rodent ventilator delivered room air as 7 L/g 100ϫ per min. Mice were randomly assigned before the experiment to undergo either bronchoalveolar lavage or lung harvest after the experiment. A polyethylene catheter was placed in the ventral tail vein and secured. Continuous pulse oximetry measured arterial hemoglobin O 2 saturation (MouseOx, rodent-specific pulse oximeter; Starr Life Sciences, Oakmont, PA) and was recorded electronically. For RBC transfusions, 10 L/g body weight of a 35% hematocrit RBC suspension in PBS was warmed to 37°C and then infused over 10 secs intravenously. Ten mins after SaO 2 had re-equilibrated after RBC transfusion, bronchoalveolar lavage was performed using four serial 1-mL exchanges with PBS containing 0.1 mM diethylaminetetrapentaacetic acid delivered through the tracheostomy at 18 cm H 2 O pressure and recovered by gravity. Bronchoalveolar lavage fluid (BALF) cell pellets obtained by centrifugation were resuspended in Hank's balanced salt solution. Cells were counted using a hemacytometer, fixed on a Cytospin slide for differential white blood cell counts, or analyzed using a flow cytometer as indicated.
Fluorescent Labeling and Detection of Transfused RBCs. Washed RBCs were labeled with the fluorescent dye Dil (Invitrogen, Carlsbad, CA) as previously described (16) in the presence of Ca 2ϩ and Mg 2ϩ followed by washing with Ca 2ϩ-and Mg 2ϩ-free PBS containing the chelator diethylaminetetrapentaacetic acid (0.1 mM). BALF cellularity or tissues were examined under a fluorescent microscope fitted with a Texas-red filter.
Flow cytometry was performed on BALF samples after incubation with mouse (anti-TER 119) or human (anti-CD235a)-specific fluorescent antibodies (eBioscience, San Diego, CA) using a FACS Canto II Becton Dickinson instrument (San Jose, CA).
Immunohistology of Organs From Transfused Mice. In preselected experiments, lungs from nude mice transfused with Dil-labeled, fresh human RBCs pretreated with vehicle or GLIB were perfused free from intravascular blood cells with PBS (with diethylaminetetrapentaacetic acid, 0.1 mM) and inflation-fixed using 10% formalin immediately after an experiment (approximately 15 mins posttransfusion) and euthanasia. In a separate series of experiments, the lungs, spleen, and a kidney were harvested after similar experiments. Frozen tissue sections were counterstained with diamidino phenyl indole, and deposition of RBCs (fluorescence-labeled with Dil before transfusion) was identified using a Texas-red filter. Where indicated, channel-specific fluorescence intensity was quantified (Adobe Photoshop CS5, San Jose, CA).
RBC perfusion of isolated mouse lungs was performed as previously described (17) . Briefly, C57BL6 mice 9 -12 wks of age were anesthetized with ketamine/xylazine, and a Krebs-based perfusate was used at 1.0 mL/min. For RBC perfusion (0.1 mL/min), the total rate was held constant by decreasing the perfusion rate of coinfused buffer. See also Supplemental Digital Content 1 (http://links.lww.com/CCM/A270).
Statistical analysis used analysis of variance or paired or unpaired t tests with post hoc testing as appropriate. All tests in analysis of variance were compared using a Tukey's multiplecomparison test that adjusts for the number of tests within an experimental series. Given the exploratory nature of the study, we did not apply an omnibus correction for multiple testing. Analyses were performed using GraphPad (La Jolla, CA) Prism software. p Ͻ .05 was considered significant unless otherwise indicated.
RESULTS
Influence of Storage on ATP Release
From Human RBCs. RBC ATP release (extracellular accumulation) was assayed in normoxia (21% O 2 ) and hypoxia (approximately 1% O 2 ) at varying points in time after RBC collection (Fig. 1A) . Basal release of ATP (i.e., in normoxia) was evident and could not be accounted for by RBC lysis, which does increase with storage (7). RBCs were washed before assaying ATP release, and RBC lysis (mean Ϯ SEM: 1.44% Ϯ 0.17% in normoxia and 1.27% Ϯ 0.16% in hypoxia) contributed minimally to the extracellular ATP measured in our assays. As previously reported, exposure of RBCs to hypoxia increased ATP release. Under these storage conditions, hypoxia-induced release of ATP declined progressively and by 7-14 days after collection was less than half that from fresh RBCs (Fig. 1A) . Normoxic (basal) ATP release also declined progressively with storage time.
Inhibitors of ATP Release. The decline in ATP release could not be explained simply by the established decline in RBC ATP content, which remains substantial even at the 42-day expiration date for conventional storage solutions (14, 18) . Both GLIB, an inhibitor of the cystic fibrosis transmembrane conductance regulator and K ϩ ATP channels, and the pannexin 1 hemichannel-inhibitor CBX (10) inhibited ATP release from fresh RBCs during normoxia (Fig. 1B) and hypoxia ( Fig. 1C) , consistent with published reports (19, 20) . Similar results were seen whether GLIB was dissolved in dimethylsulfoxide or in a solvent containing dextrose and sodium hydroxide, and neither GLIB vehicle alone inhibited RBC release of ATP (not shown).
Adhesion of Fresh and Stored RBCs:
Influence of GLIB and Apyrase. Fresh and stored human RBCs treated with vehicle or with the ATP release inhibitor GLIB were tested for their ability to maintain adhesion to HUVECs established under static conditions when exposed to varying shear stresses. Adhesion of fresh RBCs to HUVECs was lower than that of stored RBCs (Fig. 2) . At a shear stress of 2 dynes/cm 2 , the mean percentage of adherent stored RBCs was markedly higher relative to the mean percentage of adherent fresh RBCs, which was very low (Fig. 2B) . Inhibition of ATP release by GLIB increased the adhesion of fresh RBCs ( Fig. 2A-B) . In stored RBCs, any proadhesive effect of GLIB was statistically insignificant and small in magnitude (Fig.  2B ). In the presence of ATP-hydrolyzing extracellular apyrase, the adherence of fresh human RBCs to HUVECs was markedly increased at varying shear stresses (not shown) relative to exposure to vehicle alone (mean results at 2 dynes/cm 2 are shown in Fig. 2C ). Together, these findings indicate a role for exported ATP in preventing the endothelial adhesion of healthy RBCs. choalveolar Lavage Cellularity In Vivo. In a nude mouse model of RBC transfusion, blood oxygenation (SaO 2 , Fig. 3A-B) fell in response to transfusion of untreated stored (35-42 days) but not fresh human RBCs. The decrease in oxygenation, which is also seen with greater frequency in patients transfused with older or more RBC units in some studies (1-3), typically took place beginning 40 -60 secs after transfusion, with recovery to or near baseline levels 4 -6 mins after transfusion (Fig. 3A) . We tested whether the effect of RBC storage on blood oxygenation in mice could be the result of deficient ATP release by transfusing GLIB-treated fresh RBCs (in which ATP release is depressed). Decreases in SaO 2 were seen during transfusion of fresh human RBCs pretreated with the ATP release inhibitors GLIB (Fig. 3A-B) or CBX (data not shown). Infusion of either the second (final) wash from GLIB-treated RBCs or a dose of GLIB equivalent to that used for RBC exposures did not lead to decreases in SaO 2 (not shown). The decreases in SaO 2 seen in mice transfused with either GLIB-treated fresh RBCs or untreated 35-to 42-day stored RBCs were accompanied by extravasation of RBCs into the alveoli as reflected in increased RBC counts in the BALF (Fig. 3C) 
Influence of RBC Storage and ATPRelease on Blood Oxygenation and Bron-
led to impaired oxygenation and lung RBC extravasation cannot be explained by an effect of leukoreduction. BALF accumulation of leukocytes in transfused mice did not differ as a function of RBC storage or ATP release inhibition and predominantly reflected (resident) macrophages in all cases (see Supplemental Fig.  S1 , Supplemental Digital Content 2, http://links.lww.com/CCM/A277). When fresh RBC transfusates were pre-exposed to the fluorescent dye Dil, sequestration of fluorescent RBCs within the lung was increased by prior exposure to GLIB vs. vehicle (Fig. 3D-F) . In a separate series of RBC transfusion experiments, we harvested spleens, lungs, and kidneys from mice. The results indicate that sequestration of transfused human RBCs in the mouse kidney was minimal relative to that seen in the lung or spleen. In addition, no obvious differences were seen in either the spleen or the kidney in the sequestration of transfused RBCs as a function of RBC pre-exposure to GLIB (n ϭ 4 for GLIB vs. n ϭ 3 for vehicle) as was prominent in the lung (see Supplemental RBC ATP Release and Deformability. Conceivably, the in vitro or in vivo effects of GLIB or CBX could be mediated by changes in RBC deformability, which is sensitive to intracellular ATP and is known to decline during storage (21) . However, GLIB did not change the intracellular ATP concentration in stored or fresh RBCs (not shown [12] ). To test for a possible rheologic action of GLIB or CBX, we measured RBC deformability in their presence and absence. Relative to exposure to vehicle alone (or no exposure, not shown), neither GLIB nor CBX altered the ability of RBCs to deform in response to a physiological range of shear stresses (see Supplemental Fig. S3 , Supplemental Digital Content 4, http://links.lww.com/CCM/A279). A similar lack of effect of GLIB treatment on RBC rheology was reported using a different assay (RBC filterability) (12) . 
Influence of Extracellular ATP on Adhesion of GLIB-Treated Fresh RBCs to
Endothelial Cells. To confirm that the proadhesive effect of GLIB was in fact the result of the suppressed release of ATP from RBCs (as opposed to another, nonspecific effect), we compared adhesion of GLIB-treated fresh human RBCs in the absence or presence of authentic ATP added with the RBC suspension or applied to the HUVECs just before adhesion assays. The adhesion to HUVECs of GLIBtreated RBCs was markedly reduced when the RBC suspension contained supplemental (extracellular) ATP (Fig. 4A) , consistent with an effect of GLIB specific to its inhibition of ATP release and suggesting that in control experiments, the released ATP (or a metabolite) was active. The reversal of the GLIB effect by ATP was identical when HUVECs were exposed to ATP just before exposure to GLIBtreated RBCs, also consistent with an extracellular action of RBC-derived ATP to inhibit adhesion of RBCs to endothelial cells.
Influence of Extracellular ATP on Responses to Transfusion of GLIB-Treated Human RBCs
In Vivo in Mice. Nude mice were transfused with GLIB-treated fresh human RBCs supplemented with the stable, nonhydrolyzable ATP analog ATP-␥-S at a calculated final concentration in plasma of 1 M, approximating the increase in plasma ATP predicted by in vitro RBC-ATP experiments. (Infused ATP itself is vulnerable to hydrolysis by ectonucleotidases in vivo.) With coinfusion of ATP-␥-S, blood oxygenation was preserved in contrast with the effect of transfusing GLIB-treated fresh RBCs alone and consistent with the inhibition of ATP release accounting for the GLIB effect in vivo (Fig. 4B) . By contrast, inclusion in the RBC suspension of the ATP precursor/metabolite adenosine did not attenuate the decrease in blood oxygenation seen in response to transfusion of GLIBtreated fresh human RBCs (not shown). Increases in BALF RBCs were also blunted when extracellular ATP-␥-S was infused together with the GLIB-treated RBCs (Fig. 4C) . Taken together, these results suggest (but do not directly demonstrate) that ATP release from RBCs acts to limit the adhesion of transfused RBCs.
Effect of RBC Storage on Vascular Resistance in RBC-Perfused Lungs. Perfusion of isolated mouse lungs allows direct measurement of changes in vascular resistance and eliminates leukocyte-RBC interactions because the lungs are first perfused free from native white blood cells and RBCs (17) . In lungs perfused with human RBCs suspended in a physiological, isotonic Krebs buffer, increasing duration of RBC storage correlated directly with increases in both basal peak airway pressure, reflecting peripheral vascular resistance (see Supplemental   Fig. S4 , Supplemental Digital Content 5, http://links.lww.com/CCM/A280), and mean peak airway pressure during hypoxia (hypoxic pulmonary vasoconstriction, not shown). The effect of RBC storage on peak airway pressure recapitulates that of pretreatment of fresh RBCs with GLIB (increased peripheral vascular resistance and hypoxic pulmonary vasoconstriction) demonstrated previously in a similar model (22) . These data are consistent with the hypothesis that the RBC storagedependent increases in peak airway pressure involve the progressive loss of the ability of stored RBCs to release ATP.
Identity of Surface Receptor(s) Mediating ATP-Sensitive Adhesion.
The influence of antibodies to candidate erythrocyte adhesion receptors was examined in fresh human RBCs treated with the ATP release inhibitor GLIB (Fig. 5A) . Incubation of RBCs with antibody (Ab) to the adhesion receptor LW (intercellular adhesion molecule-4) largely prevented the GLIBinduced increases in endothelial adhesion, whereas RBC exposure to Abs to CD44 or CD47 (hyaluronan and thrombospondin receptors, respectively) or the nonreactive monoclonal murine IgG P3 had no effect relative to GLIB treatment alone (Fig. 5A) . Exposure of HUVECs to an anti-␣ v ␤ 3 mAb, but not to an anti-CD44 mAb, prevented endothelial adhesion of GLIB-treated fresh human RBCs (Fig. 5B) .
Influence of Adhesion-Receptor Abs on Decreases in Oxygenation and BALF RBCs in Mice Transfused
With GLIBExposed RBCs. We compared changes in oxygenation and BALF RBC accumulation in mice transfused with GLIBtreated fresh RBCs exposed to Abs against the adhesion receptors LW (intercellular adhesion molecule-4) or CD47. Exposure to anti-LW Ab, but not to the anti-CD47 Ab, mitigated the decrease in oxygenation (Fig. 5C ) and prevented the increase in BALF RBCs (Fig. 5D ) seen in mice transfused with RBCs exposed to the ATP release inhibitor. 
Flow Cytometric Analysis of Bronchoalveolar Accumulation of Cells
Role of ATP Release in Responses to Transfusion of Murine RBCs.
We performed experiments to determine whether the effect of ATP release inhibition on responses to transfusion of human RBCs was attributable in part to an effect related to the larger size of human RBCs relative to mouse lung microvessels. Nude mice were transfused with either GLIB-treated or control (vehicle-exposed) fresh RBCs from C57BL6 wild-type mice. Although generally smaller than those seen in response to human RBCs, decreases in blood oxygenation were also seen when murine RBCs were transfused (Fig. 6A) . Greater BALF RBC counts were also seen after transfusion of GLIB-treated vs. vehicle-treated murine RBCs (Fig. 6B) . This further suggests that the effect on blood oxygenation is caused by impaired ATP release from RBCs and indicates that under the conditions used, the larger size of human RBCs alone did not account for the changes in blood oxygenation we observed.
DISCUSSION
Changes in human RBCs during conventional storage are numerous and complex, and despite extensive investigation, there is little established regarding causal links between any particular biochemical or functional change and the suboptimal clinical outcomes after RBC transfusion (1) (2) (3) (4) . Recent studies have focused on storage-induced loss of RBC-dependent vasoactivity (6, 7), whereby RBCs respond to falling O 2 tension or mechanical stress by increasing blood flow so that O 2 delivery rises appropriately (8, 19, (23) (24) (25) .
The principal new findings from this study are that the inducible and basal release of ATP from human RBCs declines as a function of storage time and that this ATP-related RBC "storage lesion" results in increased endothelial adhesion of RBCs in vitro and sequestration of RBCs in the lungs of transfused mice in vivo. The proadhesive loss of the RBC's ability to release ATP is a newly identified mechanism by which transfusion of older, banked RBCs may contribute to declines in O 2 transport relative to younger, fresh RBCs. Indeed, transfusion of older RBCs produced modest hypoxemia, likely reflecting interference with the normal uptake of O 2 by RBCseither native or transfused-sequestered in the lung. This RBC storage lesion-like the recognized losses of vasodilator S-nitrosothiols (7) and O 2 affinity-regulating 2,3-BPG-may therefore interfere with normal O 2 delivery in the transfused patient. More generally, these data demonstrate a novel role for ATP released from the normal RBC as an antiadhesive agent.
Impaired ATP Release as a Novel RBC Storage Lesion. Progressive loss of ATP content during RBC storage, although reduced with the use of current additive solutions, is well documented and has been implicated in the progressive cytoskeletal and morphologic changes in RBCs and the storage-induced decline in RBC deformability. The decline in RBC deformability could impair microvascular blood flow. However, while storage-induced decreases in ATP content are well established, our study is the first to directly examine whether the ability of RBCs to export ATP declines accordingly (or faster) during storage. The storage-induced progressive loss of the RBC's ability to release ATP upon stimulation and the related increase in RBC adhesion to endothelium together represent a novel RBC "storage lesion" potentially amenable to correction.
Actions of ATP Exported by the RBC. Ellsworth, Sprague, and others have demonstrated that RBCs release ATP in response to falling pO 2 or mechanical deformation; the released ATP presumably functions to produce local vasodilation as needed to ensure adequate O 2 delivery (8). This promotes unfettered passage of the RBC through microvessels, a process that frequently requires that the RBC deform. In the present study, we demonstrate that released ATP also normally acts to prevent or limit the adhesion of RBCs to the endothelium. Additionally, in mice transfused with RBCs treated with either of two chemically and mechanistically distinct ATP release inhibitors, sequestration of RBCs within the lung was seen. ATP-sensitive adhesion of RBCs to endothelial cells in vitro and sequestration of RBCs in vivo were largely prevented by supplemental, extracellular ATP, confirming that the proadhesive actions of GLIB resulted from the inhibition of ATP release, rather than from another, nonspecific effect. Loss of the ability of stored RBCs to export ATP may therefore promote RBC trapping in the microcirculation of the lung or other organs, impeding blood flow. These new findings point to a previously unrecognized cellular pathway potentially involved in the initiation or progression of tissue injury when RBCs are transfused after longer storage times.
Proadhesive Effects of RBC Storage. Storage-induced increases in adherence of normal human RBCs to endothelial cells in vitro have been reported and vary with leukoreduction, endothelial cell source and activation status, and other factors (26 -28) . Our finding of increased adhesion of stored RBCs (relative to fresh) is consistent with some reports (27, 28) , and this study is the first describing a link between deficient ATP release and RBC adhesion. We demonstrated that an Ab to the erythrocytic adhesion receptor LW/intercellular adhesion molecule-4 selectively blocked the induced increases in RBC adhesion in vitro and decreases in blood oxygenation in vivo secondary to ATP release inhibition, consistent with a role for LW in the ATP-sensitive, increased adhesion of RBCs. We showed that addition of ATP to HUVECs prevented GLIB-induced RBC adhesion and that ATP-sensitive RBC adhesion to HUVECs appears to involve the endothelial ␣ v ␤ 3 integrin, a known counterreceptor for LW/intercellular adhesion molecule-4 previously shown to mediate adhesion to endothelium in vitro and in vivo (15, 29) . In the previous work, LWdependent adhesion could be upregulated by either activation of the RBC LW receptor or activation of the target endothelial cells. Precisely how ATP exported by the RBC limits LW-dependent adhesion to endothelial cells is unknown and is the subject of ongoing investigation.
RBC Export of ATP and Extravasation. Loss of the ability of RBCs to release ATP-either as a consequence of conventional storage or via pharmacologic inhibition-was associated with lung sequestration of RBCs and extravasation of RBCs into the air spaces. The depressed oxygenation and increase in BALF RBC count after transfusion of stored or GLIBtreated human RBCs in nude mice appeared to depend little or none on the species difference, because 1) gas exchange changes and BALF RBC counts were minimal in mice transfused with fresh, untreated human RBCs; and 2) nude mice transfused with GLIB-treated murine RBCs also exhibited the abnormal pulmonary phenotype. Thus, interspecies incompatibility did not compromise the ability of our mouse model to allow the study of how adverse and potentially significant changes during the banking of human RBCs may promote adverse and disappointing clinical outcomes in transfused human patients.
We observed that when human RBCs with impaired capacity to release ATP were transfused into nude mice, the extravasating RBCs were overwhelmingly murine (native) in origin (Ն1000:1 ratio of mouse:human RBCs in BALF). The preferential extravasation of native RBCs may partly reflect the difference in RBC size (human Ͼ mouse) and is poorly explained by the posttransfusion circulating mouse RBC:human RBC ratio, which was approximately 20 (data not shown). In nude mice transfused with human RBCs, therefore, the adherent RBCs are generally not the ones that extravasate. Pulmonary edema is recognized clinically when red color is noted in respiratory secretions. The underlying increases in the permeability of the pulmonary capillary endothelium permit the entry of not only water and plasma but also circulating red and white blood cells, but the specific mechanisms governing RBC extravasation are poorly defined. ATP is a known regulator of endothelial permeability, and it is possible that ATP released from RBCs modulates extravasation and injurious accumulation of RBCs in the alveoli. Neutrophils (polymorphonuclear leukocytes) can also release ATP which can, in turn, modulate polymorphonuclear leukocyte-endothelial adhesion (30, 31) ; but whether ATP exported from the RBC may modulate polymorphonuclear leukocyte adhesion (and vice versa) is unknown. Further studies are needed to determine the precise nature of and possible links between ATP-sensitive increases in RBC adhesion, endothelial permeability in the lung, and RBC extravasation into the alveolar air spaces.
Organic Phosphate Repletion in Stored RBCs. There has recently been renewed scientific and clinical interest in exploiting established techniques for the augmentation of organic phosphates within RBCs as a means to improve the O 2 delivery function of older stored RBCs (32) . Whereas the Food and Drug Administration-approved solution Rejuvesol (enCyte, Braintree, MA) was originally developed principally to restore 2,3-BPG to normalize O 2 affinity in the stored RBC, exposure of older RBCs to this solution also raises intra-RBC levels of ATP. Thus, this approach could also improve the flow of stored RBCs, because RBC ATP is considered critical to RBC properties such as deformability that influence RBC flow through arterioles, capillaries, and venules. Given our novel findings that ATP release from stored RBCs is markedly reduced and that RBC ATP appears to prevent excessive RBC adhesion to endothelial cells, an additional potential application of Rejuvesol would be to limit the proadhesive properties of RBCs transfused after weeks of storage. Specifically, whereas declines in overall intra-RBC ATP are modest even after 42 days of storage, it is unknown whether declines in ATP occur more rapidly in particular compartments such as the RBC mem-brane (33, 34) . Given the complexity of the total "storage lesion," ATP repletion alone may be insufficient to improve outcomes or even ATP release, the decline of which may involve other changes such as the progressive increases in O 2 affinity of RBCs during storage (35) , which would be expected to limit ATP release (36) . Future studies are needed to test such treatment.
Clinical Implications of RBC Adhesion After Transfusion. Increased adhesion of RBCs might contribute to adverse pathophysiology in settings in which RBC transfusion has proven disappointing such as pediatric and adult critical illness, acute coronary syndromes, and cardiac surgery. In addition to promoting regional decreases in blood flow or even vaso-occlusion, RBC adherence to endothelium may initiate or propagate inflammatory events through local release of reactive oxygen species (37) by decreasing local availability of bioactive nitric oxide species or through other mechanisms. The antiadhesive actions of RBC-derived ATP may assume greater importance under conditions of endothelial injury. In critically ill patients, therefore, RBC transfusion may represent a "second hit" after a priming event. Further work is needed to determine whether interference with the normal release from RBCs of antiadhesive ATP might contribute to the unexpectedly increased morbidity and mortality in transfused patients; additional work in relevant animal models is also needed, including testing relevant therapeutics.
CONCLUSIONS
The normal flow of RBCs in the pulmonary circulation depends in part on the release of antiadhesive ATP from RBCs. Storage-induced deficiency in ATP release from transfused RBCs may promote microvascular pathophysiology in the lung, in part through increased RBC adhesion mediated by the LW/intercellular adhesion molecule-4 receptor on RBCs and the endothelial ␣ v ␤ 3 integrin. By this mechanism, excessive adhesion of RBCs transfused after storage may contribute to the increased incidence of respiratory failure and other adverse outcomes after transfusion in the critically ill patient.
